NGM NASDAQ
NGM Biopharmaceuticals, Inc.
1W: -1.3%
1M: +0.7%
3M: +14.9%
1Y: -60.8%
3Y: -94.5%
5Y: -89.5%
$1.54
Last traded 2024-04-08 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$169M
-45.1% ▼
5Y CAGR: -7.3%
Total Liabilities
$20M
-57.7% ▼
5Y CAGR: -19.3%
Shareholders Equity
$149M
-42.7% ▼
5Y CAGR: -4.5%
Cash & Investments
$147M
-45.8% ▼
5Y CAGR: -6.6%
Total Debt
$0
-100.0% ▼
Net Debt
-$59M
+13.6% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $246M | $147M | $152M | $73M | $59M |
| Short-Term Investments | $99M | $148M | $214M | $198M | $88M |
| Cash & ST Investments | $345M | $295M | $366M | $271M | $147M |
| Net Receivables | $5M | $6M | $5M | $8M | $58K |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $6M | $7M | $8M | $10M | $9M |
| Total Current Assets | $355M | $308M | $379M | $289M | $156M |
| Property, Plant & Equip. | $19M | $15M | $14M | $11M | $7M |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $2M | $1M | $1M | $4M | $2M |
| Other Non-Current Assets | $4M | $5M | $7M | $4M | $3M |
| Total Non-Current Assets | $25M | $21M | $23M | $19M | $12M |
| Total Assets | $380M | $329M | $402M | $307M | $169M |
| — Liabilities — | |||||
| Accounts Payable | $9M | $10M | $5M | $8M | $3M |
| Short-Term Debt | $0 | $0 | $5M | $5M | $0 |
| Deferred Revenue | $5M | $0 | $18M | $366K | $0 |
| Other Current Liabilities | $26M | $33M | $33M | $34M | $17M |
| Total Current Liabilities | $40M | $43M | $61M | $48M | $20M |
| Long-Term Debt | $0 | $0 | $5M | $0 | $0 |
| Other Non-Current Liab. | $10M | $6M | $0 | $0 | $149K |
| Total Non-Current Liabilities | $10M | $6M | $5M | $14M | $149K |
| Total Liabilities | $50M | $49M | $67M | $48M | $20M |
| — Equity — | |||||
| Common Stock | $67K | $71K | $78K | $82K | $83K |
| Retained Earnings | -$196M | -$299M | -$419M | -$582M | -$724M |
| Accumulated OCI | $25K | $4K | -$129K | -$302K | $18K |
| Total Stockholders Equity | $331M | $280M | $336M | $260M | $149M |
| Total Liabilities & Equity | $380M | $329M | $402M | $307M | $169M |
| — Key Metrics — | |||||
| Total Debt | $0 | $0 | $10M | $5M | $0 |
| Net Debt | -$246M | -$147M | -$141M | -$68M | -$59M |
| Total Investments | $101M | $150M | $216M | $202M | $91M |